Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Gross Margin (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Gross Margin for 16 consecutive years, with 14.27% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gross Margin fell 777.0% year-over-year to 14.27%, compared with a TTM value of 15.15% through Sep 2025, down 176.0%, and an annual FY2024 reading of 17.23%, up 682.0% over the prior year.
  • Gross Margin was 14.27% for Q3 2025 at Rockwell Medical, down from 15.57% in the prior quarter.
  • Across five years, Gross Margin topped out at 22.03% in Q3 2024 and bottomed at 14.54% in Q4 2021.
  • Average Gross Margin over 5 years is 8.42%, with a median of 12.12% recorded in 2022.
  • The sharpest move saw Gross Margin crashed -1708bps in 2021, then surged 2667bps in 2022.
  • Year by year, Gross Margin stood at 14.54% in 2021, then skyrocketed by 183bps to 12.12% in 2022, then grew by 7bps to 12.99% in 2023, then grew by 13bps to 14.72% in 2024, then fell by -3bps to 14.27% in 2025.
  • Business Quant data shows Gross Margin for RMTI at 14.27% in Q3 2025, 15.57% in Q2 2025, and 16.08% in Q1 2025.